Congenica has been at the heart of the UK's genomic medicine journey for over a decade, from the 100,000 Genomes Project to today's NHS GLHs. As part of the SeqOne family, we bring even greater capacity, innovation, and longevity to the labs and clinicians who depend on us.
Clinical excellence born from the Wellcome Sanger Institute, and trusted by national programs like Genomics England and the NHS.
Forming a leading force in genomic strusted by laboratories in 35+ countries, bringing together software innovation and clinical expertise.
Delivering over 200,000 patient analyses annually with clinical-grade accuracy, demonstrating proven capacity at population scale.
Backed by €20M in recent funding with a 125+ person team of developers, scientists, and clinical experts accelerating breakthrough innovation.
Advanced NGS Platform
Our AI-powered genomic analysis platform transforms raw sequencing data into fast, actionable clinical insights across rare disease, oncology, and infectious diseases, empowering labs to deliver personalized medicine at scale.
Discover
Clinical Interpretation Services
Our Clinical Interpretation team is a group of NHS-trained genomic experts who work alongside your lab to deliver fast, rigorous variant analysis and clinical reporting you can trust.
Learn moreBuilt on Congenica's proven rare disease foundations. Now extending clinical-grade analysis into oncology and infectious disease, on a single platform.
Identify acquired mutations in cancers.
Pinpoint germline variants.
Detect microbial pathogens.
The platform of choice for ambitious national genomics initiatives, worldwide.
Figures forged in live clinical environments, on real patient cases.
Genomic infrastructure is a long term decision. We have the team and the backing to stay ahead.
